• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    The Dual Regulatory Roles of Macrophages in Acute Allogeneic Organ Graft Rejection

    2022-06-11 09:01:38LiangTanYinanGuoChangFengYangxiaoHouXubiaoXieYongZhao
    Engineering 2022年3期

    Liang Tan, Yinan Guo, Chang Feng, Yangxiao Hou, Xubiao Xie*, Yong Zhao*

    a Kidney Transplantation Department, The Second Xiangya Hospital of Central South University, Changsha 410011, China

    b State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China

    c Cunji Medical School, University of Chinese Academy of Sciences, Beijing 100049, China

    d Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing 100101, China

    Keywords:Macrophages Transplantation Tolerance Rejection Regulatory macrophage

    ABSTRACT Innate immune cells are critical for transplant response. As an important cellular component of innate immune cells, macrophages are the predominate infiltrated cells in allografts, and macrophage accumulation in allografts is negatively associated with the short- and long-term outcomes of organ transplantation.Macrophages are functionally heterogeneous and plastic.They participate in organ graft rejection through multiple pathways, including antigen presentation, the expression of costimulatory molecules and cytokines, and direct cytotoxicity and injury ability to allografts. However, some macrophage subpopulations,such as regulatory macrophages,can protect allografts from immune rejection and promote transplant immune tolerance with their immune regulatory properties. Although researchers recognize the potential roles macrophages play in allograft injury, they pay insufficient attention to the diverse roles of macrophages in allograft rejection. We herein briefly summarize the distinctive roles of macrophages in acute transplant immune response and the effect of immunosuppressive drugs on macrophages. Greater attention should be paid to the complex and critical function of macrophages in allograft rejection,and more effort should be put into developing immunosuppressive drugs that specifically target macrophages, which would ultimately improve the long-term survival of organ grafts in patients.

    1. Introduction

    Transplantation is the optimal therapy for treating end-stage organ diseases,although transplant rejection remains a major limitation for long-term allograft survival. In general, after allografts are implanted,the innate immune cells start to mediate the innate immune response and inflammation;subsequently,the host adaptive response is activated to reject allogeneic organ grafts [1]. The limited effectiveness of improving long-term graft survival by current immunotherapeutic strategies that mainly, if not exclusively,target adaptive immune cells has prompted researchers to pay more attention to other immune cells beyond adaptive immune cells in mediating allograft rejection. In fact, innate immune cells such as dendritic cells (DCs), macrophages, and natural killer(NK)cells are closely involved in graft rejection,in addition to having inflammatory effects [2–4]. Moreover, there is compelling evidence that the role of innate immune cells in transplant immunity goes far beyond the traditional concept that innate immune cells participate in organ graft rejection predominantly by means of inflammation and their antigen-presenting ability [5–8], and it is believed that non-T cells, especially innate immune cells, are becoming more important in transplant responses [5,6].

    Macrophages are highly heterogeneous and plastic cells whose phenotype and function are greatly regulated by their microenvironments [1,9–11]. Traditionally, na?ve macrophages (M0) are functionally polarized into two subsets: M1 and M2 macrophages[12–16].M1 is induced by interferon(IFN)-γ or lipopolysaccharide(LPS) + IFN-γ, and so forth, and its polarization relies on signal transducer and activator of transcription 1 (STAT1). M1 produces interleukin (IL)-1, IL-6, tumor necrosis factor (TNF)-α, and nitric oxide; it then associates with T helper 1 type (Th1) immune responses. M2 is induced by IL-4 and IL-13, and its polarization depends on STAT6.M2 produces IL-10,transforming growth factor(TGF)-β, and arginase. Functionally, M1 exhibits proinflammation and tissue injury capacities, whereas M2 has anti-inflammation,tissue repair, and pro-fibrosis functions. Moreover, it has been recently demonstrated that IL-23 can induce a unique subpopulation of macrophages mainly producing IL-17A, IL-17E, and IL-22[17], and that M0 can also be polarized to haemoglobin/haptoglobin complexes-induced macrophages (HA-mac/M(Hb)), and heme-induced macrophages (Mhem) [18]. In addition, some macrophage subpopulations, such as regulatory macrophages(Mregs), exhibit the immunosuppressive function (Fig. 1).

    Macrophages are the dominant infiltrated cell types in allografts during rejection episodes,and graft-infiltrated macrophages are closely associated with both the short- and long-term outcomes of organ transplantation [19–23]. Therefore, the role of macrophages in allo-immunity is very important, especially when the host adaptive response is inhibited. Einecke et al. [24]described the dynamic changes of macrophages in murine kidney allografts. These allografts exhibited increased macrophage activation-associated transcripts(including allograft inflammatory factor 1 (Aif1), nitric oxide synthase 2 (Nos2), and TNF-α) at one day post-transplantation and increased inner-graft macrophages from two days post-transplantation, followed by a progressive increase. Macrophages may contribute to transplant rejection through distinct pathways such as antigen processing and presentation,costimulatory signals,cytokine productions,cross-talk with other immune cells, and immune regulation. Importantly, we recently demonstrated that macrophages can directly mediate transplant organ or tissue graft rejection [8]. In addition, Mregs have been found to participate in immune tolerance to allografts in certain transplantation tolerance induction protocols [25–27].In allo-immunity,macrophages may be the therapeutic target after organ transplantation [7]. In fact, research in murine cardiac allograft transplantation has shown that selectively inhibiting allograft-infiltrated macrophages using a nanotechnology approach efficiently promoted transplant tolerance [28,29]. In the present manuscript, we will discuss the distinctive roles macrophages play in organ transplantation, including the mechanisms of macrophages in graft rejection, the protective effects of immunosuppressive macrophages in organ graft acceptance, and the effect of immunosuppressive drugs on macrophages in transplantation settings.

    2. Accumulation of macrophages in allografts

    Due to ischemia and reperfusion injury (IRI), inflammation,tissue damage, or other reactions, innate immune responses are inescapable after transplantation [30,31]. Many proteins are upregulated in allografts. In murine kidney allografts, IFN-γinducible transcripts (including ubiquitin D (Ubd), C–X–C chemokine ligand 9 (CXCL9), CXCL10, and CXCL11) were found to have progressively increased and macrophage activation-associated transcripts (including Aif1, Nos2, and TNF-α) to have significantly increased in allografts one day after transplantation [24].Allograft-produced trafficking proteins have been shown to promote the graft infiltration of macrophages, including monocyte chemotactic peptide (MCP)-1; intercellular adhesion molecule(ICAM)-1;vascular cell adhesion molecule(VCAM)-1;macrophage inflammatory protein(MIP)-1α;regulated-on-activation,normal T cell-expressed and secreted chemokine (RANTES); and macrophage migration inhibitory factor (MIF) [32–37]. IRI has also been shown to promote inner-graft lipocalin-2(Lcn2)expression,which enhanced macrophage infiltration into murine cardiac grafts [38].

    Cellular interactions are also important for macrophage graft infiltration. It has been demonstrated that macrophage graft infiltration requires help from cluster of differentiation 4+(CD4+) T cells [39], and it has even been hypothesized that macrophage graft infiltration is caused by T cell activation [40]. Moreover, the absence of B cells has been found to inhibit macrophage infiltration into rat kidney allografts[41].In line with this interaction,macrophages were shown to increase dramatically in kidney allografts suffering acute rejection [42].

    Fig.1. The roles of macrophage subsets in transplant immunity.M0 macrophages can be polarized into M1 and M2.M1 macrophages have a proinflammation effect,while M2 macrophages mainly have an anti-inflammation effect and promote vasculopathy and fibrosis.Allograft-infiltrated macrophages in acute rejection are mainly M1,while those in chronic rejection are M2.M0 can also be polarized to M17,HA-mac/M(Hb),and Mhem macrophages,although studies on their effects in transplant immunity are still limited. M0 can differentiate to Mregs, which exhibit an immunosuppressive function in transplant immunity.

    In addition to graft infiltration,macrophages present active proliferation in allografts [21,43,44]. Macrophage colony-stimulating factor (M-CSF) expression, which can promote the proliferation of macrophages, is significantly upregulated in allografts and in graft-infiltrated macrophages. In murine kidney allograft transplantation under acute rejection conditions, the M-CSF receptors c-FMS were restricted to graft-infiltrating macrophages, and antic-FMS antibody treatment significantly reduced the accumulation and local proliferation of macrophages in allografts[43,44].Therefore, graft infiltration and inner-allograft proliferation contribute to the accumulation of macrophages in allografts, and targeting macrophage recruitment and proliferation might be an effective strategy for inhibiting allograft rejection.

    3. Macrophage and allograft rejection

    3.1. Effect of stimulatory signals of macrophages on host adaptive response

    As antigen-presenting cells, macrophages can stimulate host adaptive response through three signals: major histocompatibility complex (MHC)–peptide complex, co-stimulation, and cytokines.In regard to the role of macrophages in rejection, Jose et al. [43]summarized the potential mechanisms: First, macrophages serve as allo-antigen presenting cells; second, they produce proinflammatory cytokines to promote the inflammatory response; third,they release nitic oxide and reactive oxygen species (ROS) to take part in antibody-dependent and cell-mediated cytotoxicity; and fourth, they release profibrotic factors and matrixmetalloproteases to promote scar formation. Benichou et al. [30]also concluded that macrophages produce a wide variety of cytokines for cytotoxicity inflammation, including IFN-α/γ, TNF-α, IL-1,IL-6, IL-12, IL-18, IL-15, ROS, and granulocyte CSF (G-CSF).

    Recently,the role of CD47 on macrophages has attracted a great deal of attention from the research community. Two decades ago,the signal regulatory protein α(SIRPα)–CD47 pathway was identified and was discovered to regulate macrophages by distinguishing self- and non-self-antigens and their phagocytosis [45]. CD47 is broadly expressed by virtually all cells and is termed a ‘‘don’teat-me” signal, while SIRPα can be expressed by monocytes,macrophages, DCs, and granulocytes [46]. The role of SIRPα–CD47 interaction in cancer, autoimmunity, allotransplantation,and xenotransplantation has been identified.In allograft transplantation, CD47 expression on allografts may play distinct roles at different phases of transplantation.

    First, CD47 expression on donor cells may benefit donor antigen-induced tolerance.Donor-specific transfusion(DST)before transplantation is useful to induce transplant tolerance, and CD47 expression on donor cells may be essential for allo-tolerance induced by DST. In murine skin transplantation, the absence of CD47 on donor cells result in a failure to prolong skin graft survival,and inhibit allo-responses[47,48].This effect has also been shown in murine skin allograft transplantation following hepatocyte transplantation [49]. Zhang et al. [49] found that CD47-deficient allo-hepatocytes induced a more intense allo-response in the host in comparison with wild-type allo-hepatocytes. Mice with CD47-deficient allo-hepatocyte transplantation exhibited a higher capacity to reject the skin grafts in comparison with mice with wild-type allo-hepatocyte transplantation. In murine cardiac allograft transplantation, the elimination of CD47 on cardiac allografts induced the long-term survival of allografts in MHC-I and/or MHC-II mismatched host mice [50].

    Second, the expression of CD47 on allografts may improve IRI.In rat kidney transplantation, rat steatotic liver transplantation,and porcine cardiac allograft transplantation, CD47 blockade,which was used to perfuse grafts prior to transplantation,has been shown to reduce the IRI of allografts and improve graft function and survival [51–53].

    Third, CD47 expression on allografts may be essential to the stable function and tolerance of allografts. In rat allogenic kidney transplantation, blocking SIRPα or CD47 with monoclonal antibody can break the established kidney allograft immune tolerance, as indicated by kidney allograft dysfunction and rejection episodes [54]. Nevertheless, the roles of macrophages and CD47 in transplant immunity need to be further determined.

    3.2. Macrophages and acute rejection

    Fig. 2. Macrophages trigger and amplify the adaptive immune response to organ allo-grafts. Organ graft damage and other immune cells cause macrophage infiltration to allografts. The recruited macrophages can proliferate locally to increase the cell number. Macrophages can trigger and amplify the adaptive immune response through antigen presentation, costimulatory signals, and cytokine production.

    In acute rejection, macrophages can serve as the antigenpresenting cells in adaptive responses(Fig.2); however, the direct rejecting role of macrophages cannot be ignored. In the rat acute rejection model,deletion of macrophages was shown to potentially prolong cardiac allograft survival with a preserved function[55].It has been reported that macrophages accounted for 80% of graftinfiltrated human leukocyte antigen (HLA)-DR+cells in human allografts[21].This finding means that allograft-infiltrated macrophages preserve strong antigen presentation ability. In addition, it has been found that the numbers of allograft-infiltrated macrophages correlate with the severity of T cell-mediated rejection[21,56]. Data from human percutaneous renal biopsies showed that macrophages accounted for 52%of the infiltrated cells in allografts suffering mild rejection and 60% of the infiltrated cells in allografts suffering severe rejection [56]. Moreover, allograftinfiltrated macrophages were skewed to M1 polarization in acute rejection [54,57,58]. Intravascular activation of macrophages is associated with acute vascular rejection, and those activated macrophages may contribute to myocyte necrosis by compromising blood flow in small vessels, as evidenced by biopsy specimens of heart transplant patients [59].

    3.3. Macrophages and chronic rejection

    Chronic rejection is the most important barrier to long-term allograft survival; unfortunately, treatment options for chronic rejection are still limited [60,61]. Vasculopathy and interstitial fibrosis are the major pathological hallmarks of chronic rejection,and macrophages play an important role in the development of these pathological changes.Macrophage depletion has been shown to significantly reduce murine cardiac allograft vasculopathy [62].It has also been demonstrated that macrophage infiltration is associated with tubular injury and fibrosis progression [20]. Macrophages can promote fibrosis through two mechanisms: by promoting the accumulation, proliferation, and activation of fibroblasts; or by transiting into myofibroblasts [63]. M2 macrophages can produce TGF-β, which is the primary factor driving fibrosis [64]. In allografts suffering ongoing injury, macrophage–myofibroblast transition (MMT) has been observed. In human kidney allografts suffering chronic injury, M2 macrophages were co-located with α-smooth muscle actin (SMA)+myofibroblasts in the areas of active interstitial fibrosis[65];MMT was also obvious,characterized by a large amount of CD68+α-SMA+MMT cells, predominantly with M2 polarization [66].

    M2 polarization is predominant in graft-infiltrated macrophages in allografts suffering chronic rejection [20,39,60,65,67].Human renal allograft biopsies taken one year after transplantation showed that 92%of graft-infiltrated macrophages had M2 polarization[20].In murine cardiac allografts under chronic rejection conditions, M1 macrophage markers (IL-1β, IL-6, IL-15, IL-18, TNF-α,and Nos2) increased at two weeks but decreased by six weeks,whereas the M2 macrophage markers (a member of the chitinase family (Ym1), found in inflammatory zone 1 (Fizz1), vascular endothelial growth factor (VEGF), TGF-β, and CD206) increased by six weeks [39].

    In terms of the role of macrophages in allograft vasculopathy and interstitial fibrosis, some regulatory pathways have been defined. Mammalian target of rapamycin (mTOR) and tumor necrosis factor receptor associated factor 6 (TRAF6) are pivotal in M1 and M2 polarization [6]. Deficiency of mTOR can impair M2 polarization, and then inhibit the chronic rejection of murine cardiac allografts,while TRAF6 deficiency can impair M1 polarization,and then induce severe vasculopathy in murine cardiac allografts under chronic rejection conditions. Furthermore, the mTOR signal plays an important role in programmed death ligand-1 (PD-L1). It has been found that mTOR deficiency upregulates the PD-L1 expression of macrophages in murine cardiac allografts, and PDL1 blockade restored the inhibited chronic rejection caused by mTOR deficiency in macrophages [6]. Ras homolog gene family member A(RhoA)deficiency inhibited macrophages from infiltrating into murine cardiac allografts by means of downregulated C–X3–C chemokine receptor 1 (CX3CR1), and then inhibited chronic rejection [68]. In murine cardiac allograft with chronic rejection,graft-infiltrated M2 macrophages expressed purinergic P2X7 receptor (P2X7R). P2X7R antagonist treatment has been found to inhibit the M2 induction and graft infiltration of macrophages,and then significantly alleviate allograft vasculopathy and prolong allograft survival [60]. In addition, MMT can be regulated by the small mother against decapentaplegic family member 3 (Smad3)-dependent mechanism in mouse kidney allografts [66].

    Overall,macrophages promote the chronic degeneration of allografts mainly by means of M2 polarization.It seems that abolishing the effect of macrophages in allografts may effectively reduce allograft vasculopathy and interstitial fibrosis; however, more studies are needed to determine the mechanisms regulating macrophages and treatment targets in chronic rejection.

    3.4. Rejection and memory capacities of macrophages

    Traditionally,macrophages are mainly considered to propagate and amplify T and B cell-mediated adaptive immunity during allograft rejection. However, increasing evidence has demonstrated that macrophages can directly mediate allograft rejection (Fig. 3).Chu et al. [8] have demonstrated that macrophages can dominate acute rejection under certain conditions. In immunodeficient mice without T cells and B cells, adoptive transferred allogeneic antigen-primed macrophages (but not unprimed macrophages)were able to reject the skin allografts.We also found that the perforin pathway is involved in primed macrophage-mediated rejection. Other researchers have also consistently found that primed macrophages can mediate rejection through phagocytosis rather than direct killing [69]. In fact, graft-infiltrated macrophages present high phagocytic ability and protease activity [70], and allograft-induced macrophages present cytotoxic activity to allograft [71] or allo-tumor graft in a Ca2+-dependent manner [72].

    Fig. 3. Primed macrophages directly mediate allogeneic organ graft rejection. Macrophages activated in the presence of CD4+ T cells will gain the ability to directly reject allografts as effector cells. The primed macrophages may reject allografts by the perforin pathway, phagocytosis, or Ca2+-dependent pathways. CD40L: CD40 ligand.

    Chu et al. [8] have shown that macrophages exhibit antigen specificity—namely, immunologic memory—in allograft rejection.In line with our results,a recent study also found that host monocyte/macrophages acquire specific memories after encountering allo-antigens [73]. This study also interestingly found that paired immunoglobulin-like receptors(PIR)-A are involved in the development of this antigen specificity. In addition, cellular help is useful for the generation of antigen-specific macrophages. Chu et al. [8]and Liu et al. [69]have found that macrophages require help from CD4+T cells during the priming period and that the CD40/CD40 ligand(CD40L)pathway may be involved in delivering this help.

    Therefore,macrophages can directly mediate rejection and preserve immunologic memory capacity, and these functions go beyond the scope of innate immunity. Deciphering macrophage activation and functional pathways to reject allografts will help the research community develop novel therapeutic paradigms to prevent allograft rejection.

    4. Regulatory roles of macrophages and tolerance induction in transplantation

    Transplant tolerance is the ultimate goal of organ transplantation. Macrophages may play a protective role in tolerance induction through their immunosuppressive subsets (Fig. 4).Researchers do not yet agree on the definition of immunosuppressive macrophage subsets due to the shortage of specific biomarkers and the lack of a unified criterion. Suppressive macrophages are induced from bone-marrow-derived monocytes with M-CSF but without activation/maturation stimuli. These suppressive macrophages express typical macrophage phenotypes, including F4/80, CD169, CD64, and low/intermediate levels of MHC-II, but not Ly6C and Ly6G. It is believed that these phenotype macrophages may be the precursors of Mregs [74]. Mregs are induced from bone-marrow-derived monocytes with M-CSF and are activated by IFN-γ. They are the mature phenotype of macrophages and express typical markers including CD11a, CD11b, CD68,F4/80, CD14, podoplanin, CD127, CD301, CD16/32, CD64, Sialoadhesin (CD169), macrophage scavenger receptor (CD204), dectin-1,MHC-II, and CD80. However, they express low or no levels of CD86, CD40, Toll-like receptor 2 (TLR2), TLR4, Ly6C, and Ly6G[75]. Hutchinson et al. [76] used CD14–/low-HLA-DR+CD80–/low-CD86+CD16–TLR2–CD163–/lowto isolate induced Mregs. It has been reported that dehydrogenase/reductase 9(DHRS9)is a stable marker for human Mregs and can be used to distinguish Mregs from a variety of human monocyte-derived tolerogenic antigenpresenting cells [77]. It should be noted that, due to the shortage of specific biomarkers and the lack of clear definitions of Mregs and CD11b+Ly6C+Ly6G–M-MDSCs (M-MDSCs: monocytic myeloid-derived suppressor cells), some reported M-MDSCs may also be Mregs [26,27,78,79]. Therefore, clarification and precise definitions with clear standards and specific biomarkers for these cell subpopulations are urgently needed.

    Immunosuppressive macrophages are capable of inhibiting the alloreactive immune cells and inducing regulatory T cells (Tregs)or other regulatory immune cells in the transplant response(Fig. 4). Mregs can inhibit T cell proliferation by the inducible NOS (iNOS) pathway in an allo-antigen-specific or cell-contact manner [75]. Human Mregs can induce allogenic IL-10-producing T-cell immunoglobin and immunoreceptor tyrosinebased inhibitory motif domain (TIGIT)+Foxp3+(Foxp3: forkhead box P3) Tregs by the indoleamine 2,3-dioxygenase,TGF-β, retinoic acid, Notch, and progestogen-associated endometrial protein pathways [80]. It should also be noted that allogeneic donor CD4+CD25+Tregs promote the differentiation of IL-10-producing M2 macrophages in recipient mice [81]. Thus, Mregs and T cells may form a regulatory loop to downregulate immune response in recipients. It has been reported that DC-specific ICAMgrabbing non-integrin (DC-SIGN)+immunosuppressive macrophages are crucial mediators of immunological tolerance in murine cardiac allograft transplantation with anti-CD40L-induced immune tolerance [82]. The identified DC-SIGN+suppressive macrophages can inhibit CD8+T cell proliferation and infiltration to grafts and promote the expansion and graft infiltration of Tregs[82]. Simultaneous DC-SIGN engagement by fucosylated ligands and TLR4 signaling is required for the production of IL-10 and is closely involved in this tolerance induction protocol with costimulatory blockade [82]. In addition, the roles of Mregs in mixed allogeneic chimeras should be recognized, because donor macrophages maturing in chimeric mice have been shown to gain the ability to induce the recipient effector CD4+T cells differentiating into Foxp3+Tregs. Furthermore, these macrophages have the ability to stimulate third-party T cell proliferation and immune response [83]. Therefore, macrophages with regulatory function may be widely involved in transplantation immune response through multiple pathways.

    Fig. 4. The roles of immunosuppressive macrophages in allograft transplantation. Suppressive macrophages can be induced from monocytes by M-CSF, and regulatory macrophages can be induced from monocytes by M-CSF and IFN-γ.These immunosuppressive macrophages inhibit allograft rejection by suppressing effector immune cells and the induction of regulatory T cells (Tregs).

    The adoptive transfer of immunoregulatory cells as a means of establishing transplantation tolerance in clinical transplantation is now receiving significant attention and interest worldwide. Mregs may be a promising candidate cell type for avoiding allograft rejection and inducing immune tolerance, especially once an efficient and standardized manufacturing practice has been established[75,84]. The adoptive transfer of donor Mregs was shown to prolong mouse cardiac allograft survival, with synergy with shortterm rapamycin[75].It was also demonstrated that the transferred Mregs survived for less than four weeks in mice, and that an infusion of 3 million, but not 1 million immunosuppressive macrophages—on the day before transplantation prolonged mouse skin allograft survival[74].Human DHRS9+Mregs,which are developed from M-CSF (CSF1)-stimulated CD14+peripheral blood monocytes cultured with high concentrations of human serum [75,82,84–86],are currently being studied in the ONEmreg12 trial, a phase-I/II study of Mreg therapy, as a means of safely minimizing maintenance immunosuppression in kidney transplant recipients (clinicaltrials.gov: NCT02085629). Preliminary clinical research with two living-donor kidney transplant recipients indicated that the adoptive transfer of Mregs combined with low-dose tacrolimus treatment induced a good clinical outcome within 24 weeks [76].The adoptive transfer of Mregs proved beneficial to one kidney recipient during a 7-year follow-up [80]. It is clear that more subsets of Mregs and the optimal protocols for tolerance induction with the adoptive transfer of Megs should be explored in the future.

    5. Effects of immunosuppressive drugs on macrophages

    Although there is increasing evidence of macrophages’ distinct roles in transplant immunity, our understanding of the effects of mainstream immunosuppressive drugs on macrophages is still limited.In the following section,we will briefly discuss the effects of clinical immunosuppressive drugs on macrophage function(Table 1 [6,21,65,87–99]).

    5.1. Effects of mTOR inhibitors on macrophages in transplantation

    The effect of mTOR inhibitors such as rapamycin on macrophages is better defined compared with those of other immunosuppressive drugs. Our previous results also demonstrated that mTOR deletion did not change the development of macrophages but only regulated monocyte/macrophage development in the early stages via the STAT5-interferon regulatory factor 8 (IRF8)-dependent CD115-expression pathway[87].Rapamycin treatment did not inhibit the polarization of M1 macrophages but affected membrane phenotype and cytokine secretion in human macrophages. It significantly reduced the expression of CD25, TLR2,CD127, CD64, CD14, CD163, CD36, CD206, and CD209 but increased the expression of C–C chemokine receptor 7 (CCR7),CD86, and CD32 in M1 and reduced the expression of CD86,CD32, CD36, CD206, C–X–C chemokine receptor 4 (CXCR4), and CD209 in M2. Consistent with the finding that mTOR deficiency impairs M2 polarization [6], we found that rapamycin treatment negatively affected the survival of M2 macrophages [88].

    Although conditional mTOR deficiency in macrophages does not affect the kinetics of acute rejection[6],Braza et al.[89]developed a rapamycin and high-density lipoprotein nano-immunotherapy that specifically targeted myeloid cells.This agent induced a longer survival of murine cardiac allografts by enhancing Mreg expansion.In the antibody-mediated rejection of mouse cardiac allograft transplantation, mTOR inhibitors significantly reduced macrophage infiltration into cardiac allografts by reducing ezrin/radixin/moesin(ERM) phosphorylation and ICAM-1 clustering in the MHC-Iantibody-activated endothelium [99]. Aside from host macrophages,the adoptive transfer of donor Mregs before transplantation prolonged the survival of mouse cardiac allografts; this treatment was enhanced by rapamycin treatment[75].Considering the inconsistency of the roles of mTOR in macrophages across different situations and models, further research on the effects of mTOR—including mTOR complex 1 (mTORC1) and mTORC2 in animal models and clinical samples—is required.

    Table 1 The effect of immunosuppressive drugs on macrophages in transplantation.

    5.2. Effects of calcineurin inhibitors on macrophages

    Clinical retrospective studies have demonstrated that tacrolimus is superior to cyclosporine A (CsA) in inhibiting the role of macrophages in chronic rejection. Clinical studies have consistently found that CsA has a superior effect on promoting interstitial fibrosis in kidney allografts in comparison with tacrolimus [90].CsA may enhance the role of macrophages in chronic allograft injury [91]. First, CsA enhances the allograft infiltration of macrophages. It has been reported that CsA treatment promotes CCR5+and CXCR3+macrophage graft infiltration in rat kidney allograft transplantation [92]. In the kidneys of rats with CsA nephrotoxicity,significant macrophage infiltration was also observed[93].Second, CsA may enhance the production of molecules in macrophages; these molecules are involved in chronic allograft injury, such as platelet-derived growth factor (PDGF) [94]. It has been inconsistently found that CsA inhibits tissue factor expression in LPS-induced macrophages by inhibiting the nuclear factor(NF)-κB pathway and inhibits the tissue factor associated with coronary lesion and fibrin deposition[95].Interestingly,tacrolimus may not alter innate immune cell activity; however, it has been shown to preserve the anti-infection capacity of macrophages in mouse skin allograft transplantation [96]. It has also been demonstrated that tacrolimus does not disturb the phagocytosis of human monocytes to bacteria in vitro; only high concentrations of tacrolimus—not therapeutic concentrations—affect the maturation and polarization of macrophages, and the macrophage polarization is shifted to an M2-like phenotype in the presence of tacrolimus [97]. Thus, calcineurin has multiple effects on the function of macrophages in transplantation.

    5.3. Steroids to macrophages

    Steroids are also used extensively in clinical organ transplantation. In human allografts suffering antibody-mediated or T cell mediated rejection, the intensity of macrophage graft infiltration was found to be negatively associated with the effect of steroids[21]. In vitro, dexamethasone-treated human monocyte-derived macrophages expressed higher M2 markers and profibrotic cytokines, including TGF-β1, fibroblast growth factor (FGF)-2, and connective tissue growth factor (CTGF), but not M1-type cytokine TNF-α [65]. It was also observed that dexamethasone prompted the M2 polarization of rat macrophages in vitro [98]. In rats with induced mesangial proliferative glomerulonephritis, prednisolone treatment increased the glomerular M2 macrophages but had no effect on M1 macrophages [98]. Therefore, steroids may mainly enhance M2 polarization in transplantation settings.

    5.4. Effects of other immunosuppressive drugs on macrophages in transplantation

    To inhibit the effect of macrophages on rejection, other agents have been explored in animal and human studies. Researchers have demonstrated that mycophenolic acid (MPA) did not disturb the phagocytosis of human monocytes to bacteria in vitro but increased the expression of M2 surface markers on M1 macrophages [98]. Mizoribine treatment inhibited glomerular macrophage accumulation, selectively reduced M2 macrophages in vivo,and inhibited M2 polarization in vitro [99]. The erythropoietin(EPO)analogue ARA290 prevented early rat kidney allograft injury by targeting the NF-κB pathway and following reduced macrophage infiltration[34].In allogeneic kidney transplant in rats with CsA treatment, simvastatin treatment inhibited macrophage graft infiltration and prevented allograft injury only under donor and recipient pretreatment plus daily recipient treatment [100]. In addition to inducing the long-term survival of murine cardiac allograft, anti-CD40L inhibited the graft accumulation and IFN-γ production of proinflammation macrophages [82]. A single-center clinical study with over 15 years of follow-up demonstrated that treatment with the macrophage inhibitor ibandronate was beneficial to human kidney allograft function and survival [101]. These immunosuppressive drugs may have potential applications in clinical transplantation after further study.

    Further studies are needed to define the effect of current immunosuppressive agents,which mainly target adaptive immune cells, on macrophages. The results will contribute to the development of optimal immunosuppressive agents and drug application strategies.

    6. Conclusions and perspectives

    Macrophages are the predominant immune cellular component accumulated in allografts,and may be used to predict allograft outcome. Macrophages not only trigger and amplify the adaptive immune response to donor antigens,but can also directly mediate allograft injury as effector cells.With their widely diversified function and plasticity, macrophages have many different subpopulations, including M1, M2, IL-23-induced macrophages (M(IL-23)),and Mregs. The different subpopulations of macrophages play distinctive roles in organ graft rejection.Approaches that target different subpopulations of macrophages, including inhibiting proinflammatory macrophages and promoting immunosuppressive macrophages,would offer novel therapies to avoid graft rejection and induce immune tolerance in clinical transplantation. In the future, more effort must be put into understanding the roles and molecular mechanisms of different subpopulations of macrophages in mediating allograft rejection or protection.

    Acknowledgments

    We would like to thank Mrs.Ling Li for her excellent laboratory management. This work was supported by grants from the National Key Research and Development Program of China(2017YFA0105002 and 2017YFA0104402 to Yong Zhao), the National Natural Science Foundation for General and Key Programs(C31930041 and C81530049 to Yong Zhao),Knowledge Innovation Program of the Chinese Academy of Sciences(XDA04020202-19 to Yong Zhao), the China Manned Space Flight Technology Project(TZ-1 to Yong Zhao), the National Natural Science Foundation of China (82070774), the Natural Science Foundation of Changsha(kq2007068), and the Natural Science Foundation of Hunan Province (2021JJ30965 and 2021JJ40866).

    Compliance with ethics guidelines

    Liang Tan, Yinan Guo, Chang Feng, Yangxiao Hou, Xubiao Xie,and Yong Zhao declare that they have no conflict of interest or financial conflicts to disclose.

    变态另类丝袜制服| 色吧在线观看| 欧美在线黄色| 亚洲精品一区av在线观看| 此物有八面人人有两片| 亚洲精品一区av在线观看| 人人妻,人人澡人人爽秒播| 亚洲av成人不卡在线观看播放网| 国产av在哪里看| 男女午夜视频在线观看| 精品人妻1区二区| 欧美在线黄色| 女生性感内裤真人,穿戴方法视频| 中亚洲国语对白在线视频| 国产69精品久久久久777片 | 国产免费av片在线观看野外av| 国产精品精品国产色婷婷| bbb黄色大片| 欧美最黄视频在线播放免费| 久久久久久九九精品二区国产| 亚洲av免费在线观看| 嫩草影院入口| 日韩欧美在线二视频| 不卡av一区二区三区| 男女午夜视频在线观看| 少妇裸体淫交视频免费看高清| 精品无人区乱码1区二区| 国产av麻豆久久久久久久| 国产一级毛片七仙女欲春2| 午夜免费观看网址| 午夜精品在线福利| 日日摸夜夜添夜夜添小说| 日本黄色视频三级网站网址| 国产成人福利小说| 成人性生交大片免费视频hd| 精品国产乱子伦一区二区三区| 国产精品免费一区二区三区在线| 国产亚洲精品久久久com| 人妻久久中文字幕网| 天天一区二区日本电影三级| 黄色女人牲交| 18禁裸乳无遮挡免费网站照片| www.精华液| 国产毛片a区久久久久| 97人妻精品一区二区三区麻豆| 香蕉丝袜av| 亚洲成a人片在线一区二区| 国产成人精品久久二区二区免费| 日韩成人在线观看一区二区三区| 亚洲精品中文字幕一二三四区| 亚洲一区高清亚洲精品| 久久久久国产精品人妻aⅴ院| 91av网一区二区| 国产伦人伦偷精品视频| www.精华液| 亚洲精品一卡2卡三卡4卡5卡| 99久久精品热视频| 久久午夜亚洲精品久久| 中文字幕av在线有码专区| 久久久久久九九精品二区国产| 国产一区二区激情短视频| 久久久国产成人免费| 欧美一级a爱片免费观看看| 夜夜看夜夜爽夜夜摸| 88av欧美| 美女 人体艺术 gogo| 一级毛片高清免费大全| 国产精品久久久av美女十八| 日韩av在线大香蕉| 国产精品永久免费网站| 亚洲成人免费电影在线观看| 亚洲av日韩精品久久久久久密| 亚洲人成电影免费在线| 好看av亚洲va欧美ⅴa在| av天堂在线播放| 中文字幕熟女人妻在线| 校园春色视频在线观看| 国产精品久久久久久久电影 | a在线观看视频网站| 伦理电影免费视频| 全区人妻精品视频| 九九热线精品视视频播放| xxxwww97欧美| 亚洲色图av天堂| 热99在线观看视频| 后天国语完整版免费观看| 午夜精品一区二区三区免费看| 日本黄大片高清| 变态另类丝袜制服| 免费看日本二区| 亚洲最大成人中文| 免费电影在线观看免费观看| 熟女人妻精品中文字幕| 无限看片的www在线观看| av中文乱码字幕在线| 叶爱在线成人免费视频播放| 欧美另类亚洲清纯唯美| aaaaa片日本免费| 亚洲国产欧美网| 男女午夜视频在线观看| 一边摸一边抽搐一进一小说| 最近最新中文字幕大全电影3| 成人特级黄色片久久久久久久| 中文字幕人妻丝袜一区二区| 夜夜夜夜夜久久久久| 亚洲最大成人中文| 亚洲国产欧洲综合997久久,| 最新在线观看一区二区三区| 亚洲精品一卡2卡三卡4卡5卡| 在线免费观看的www视频| 欧美成狂野欧美在线观看| 窝窝影院91人妻| 神马国产精品三级电影在线观看| 日本a在线网址| 人妻久久中文字幕网| 在线观看66精品国产| 国产精品免费一区二区三区在线| xxxwww97欧美| 中文亚洲av片在线观看爽| 亚洲国产欧洲综合997久久,| 免费看日本二区| 一个人看的www免费观看视频| 国产欧美日韩一区二区三| 亚洲人成网站在线播放欧美日韩| 亚洲精品美女久久av网站| 亚洲人与动物交配视频| 婷婷精品国产亚洲av| 久久精品国产清高在天天线| 亚洲人成电影免费在线| 色老头精品视频在线观看| 精品国产美女av久久久久小说| 毛片女人毛片| 久久久久久久久中文| 日韩欧美国产一区二区入口| 免费看十八禁软件| 91在线观看av| 男女下面进入的视频免费午夜| 中国美女看黄片| 男女那种视频在线观看| 午夜影院日韩av| 日韩av在线大香蕉| 成人欧美大片| 在线视频色国产色| 香蕉国产在线看| 久久久久久久久中文| 日韩欧美国产一区二区入口| 一个人观看的视频www高清免费观看 | 国产精品野战在线观看| 亚洲成人精品中文字幕电影| 毛片女人毛片| 久久久久国产精品人妻aⅴ院| 宅男免费午夜| 少妇的丰满在线观看| 黄色成人免费大全| 久久久精品欧美日韩精品| 一卡2卡三卡四卡精品乱码亚洲| 在线观看免费视频日本深夜| 国产亚洲欧美在线一区二区| 精品99又大又爽又粗少妇毛片 | 亚洲成a人片在线一区二区| 国产毛片a区久久久久| 99热只有精品国产| 桃色一区二区三区在线观看| 婷婷精品国产亚洲av| 99在线人妻在线中文字幕| 美女高潮的动态| 在线a可以看的网站| 一二三四社区在线视频社区8| 国产成人aa在线观看| 熟妇人妻久久中文字幕3abv| 十八禁网站免费在线| 亚洲人成伊人成综合网2020| 网址你懂的国产日韩在线| 波多野结衣高清作品| 亚洲欧美激情综合另类| 在线观看66精品国产| 国产一区二区激情短视频| 国产v大片淫在线免费观看| 午夜两性在线视频| 免费大片18禁| 免费在线观看日本一区| 最新中文字幕久久久久 | 日本成人三级电影网站| 久久久久久久午夜电影| 黄色丝袜av网址大全| 午夜福利高清视频| 久久天躁狠狠躁夜夜2o2o| 日日夜夜操网爽| 在线视频色国产色| 久久性视频一级片| 亚洲最大成人中文| 露出奶头的视频| 国产精品久久电影中文字幕| 午夜免费成人在线视频| 后天国语完整版免费观看| 在线观看舔阴道视频| 欧美+亚洲+日韩+国产| 久久精品影院6| 成人性生交大片免费视频hd| 欧美日韩综合久久久久久 | 国产又黄又爽又无遮挡在线| 日韩成人在线观看一区二区三区| 久99久视频精品免费| 日本熟妇午夜| 久久香蕉国产精品| av黄色大香蕉| 精华霜和精华液先用哪个| 国产亚洲av嫩草精品影院| netflix在线观看网站| 久久精品国产亚洲av香蕉五月| 99精品久久久久人妻精品| 亚洲va日本ⅴa欧美va伊人久久| 国产精品一区二区三区四区久久| 蜜桃久久精品国产亚洲av| 欧美一区二区精品小视频在线| 狠狠狠狠99中文字幕| 国产成人av激情在线播放| 国产精品久久久av美女十八| 国产成人一区二区三区免费视频网站| 欧美三级亚洲精品| 18禁美女被吸乳视频| 亚洲在线观看片| 美女免费视频网站| bbb黄色大片| 亚洲专区国产一区二区| 国产黄色小视频在线观看| 淫妇啪啪啪对白视频| 美女大奶头视频| 亚洲欧美日韩高清专用| 国产精品98久久久久久宅男小说| 日韩欧美免费精品| 99久久精品一区二区三区| 久久亚洲精品不卡| 首页视频小说图片口味搜索| 国产爱豆传媒在线观看| 国产精华一区二区三区| 国产精品一区二区精品视频观看| 国产精品女同一区二区软件 | 少妇裸体淫交视频免费看高清| 亚洲在线自拍视频| 国产精品久久久久久精品电影| 精品无人区乱码1区二区| 国产亚洲精品久久久久久毛片| 国产精品精品国产色婷婷| 91老司机精品| 99久久精品热视频| 99久久综合精品五月天人人| 久久久久久人人人人人| 免费搜索国产男女视频| 超碰成人久久| 淫秽高清视频在线观看| 亚洲天堂国产精品一区在线| 久久这里只有精品中国| 亚洲精品456在线播放app | 国产97色在线日韩免费| 国产高清视频在线播放一区| 18禁裸乳无遮挡免费网站照片| 亚洲自偷自拍图片 自拍| 国产成人福利小说| 91老司机精品| 国产精品,欧美在线| 性欧美人与动物交配| 色哟哟哟哟哟哟| 99国产精品一区二区蜜桃av| 欧美乱色亚洲激情| 精品久久久久久久毛片微露脸| 真实男女啪啪啪动态图| 久久精品夜夜夜夜夜久久蜜豆| aaaaa片日本免费| 不卡一级毛片| 99riav亚洲国产免费| 国产精品乱码一区二三区的特点| 久久中文字幕人妻熟女| 久久久久久久久中文| 日韩人妻高清精品专区| 麻豆av在线久日| 成人永久免费在线观看视频| 噜噜噜噜噜久久久久久91| 国产精品一区二区免费欧美| 国产蜜桃级精品一区二区三区| 成人鲁丝片一二三区免费| 两个人的视频大全免费| 欧美乱妇无乱码| 老司机在亚洲福利影院| 99国产精品一区二区蜜桃av| 国产精品乱码一区二三区的特点| 欧美日韩乱码在线| 亚洲一区二区三区不卡视频| 黄色视频,在线免费观看| 啦啦啦韩国在线观看视频| 一区福利在线观看| 亚洲av电影不卡..在线观看| 五月伊人婷婷丁香| 美女 人体艺术 gogo| 不卡一级毛片| 香蕉国产在线看| 一二三四在线观看免费中文在| 午夜亚洲福利在线播放| 一本综合久久免费| 嫩草影院精品99| 脱女人内裤的视频| 日本精品一区二区三区蜜桃| 国产高清三级在线| 国产私拍福利视频在线观看| 精品午夜福利视频在线观看一区| av中文乱码字幕在线| 久99久视频精品免费| 动漫黄色视频在线观看| 性色avwww在线观看| 老熟妇乱子伦视频在线观看| 日韩av在线大香蕉| 手机成人av网站| 香蕉丝袜av| 亚洲av片天天在线观看| 噜噜噜噜噜久久久久久91| 亚洲 欧美一区二区三区| 国产欧美日韩一区二区三| 人妻久久中文字幕网| 午夜福利18| 18禁黄网站禁片午夜丰满| 国产一区二区三区视频了| 最近最新免费中文字幕在线| h日本视频在线播放| 91在线精品国自产拍蜜月 | 天堂影院成人在线观看| 两人在一起打扑克的视频| 亚洲自偷自拍图片 自拍| 免费av毛片视频| 亚洲人成伊人成综合网2020| 国产视频一区二区在线看| 19禁男女啪啪无遮挡网站| 97超级碰碰碰精品色视频在线观看| 搞女人的毛片| 日本 av在线| 久久午夜亚洲精品久久| 特级一级黄色大片| 他把我摸到了高潮在线观看| 18禁黄网站禁片午夜丰满| 日韩精品中文字幕看吧| 欧美黑人欧美精品刺激| 老司机午夜十八禁免费视频| 曰老女人黄片| 88av欧美| e午夜精品久久久久久久| 变态另类成人亚洲欧美熟女| 天堂√8在线中文| 国产成人欧美在线观看| 午夜两性在线视频| 一个人免费在线观看的高清视频| 欧洲精品卡2卡3卡4卡5卡区| 亚洲成人久久性| 精品免费久久久久久久清纯| 级片在线观看| 午夜福利在线在线| 国产成人精品久久二区二区91| 久久久精品大字幕| 最好的美女福利视频网| a在线观看视频网站| 香蕉久久夜色| 天堂动漫精品| 亚洲av电影不卡..在线观看| 国产高清激情床上av| 欧美成人免费av一区二区三区| 亚洲成人精品中文字幕电影| 亚洲精品456在线播放app | 午夜精品在线福利| 1000部很黄的大片| 在线观看日韩欧美| 欧美一区二区精品小视频在线| 亚洲欧美日韩高清专用| 国产高潮美女av| 真人一进一出gif抽搐免费| 欧美三级亚洲精品| 男人和女人高潮做爰伦理| 女同久久另类99精品国产91| 国产成人影院久久av| 又紧又爽又黄一区二区| 18美女黄网站色大片免费观看| 曰老女人黄片| 午夜福利在线观看吧| 一个人看的www免费观看视频| 99久久无色码亚洲精品果冻| 变态另类成人亚洲欧美熟女| 黄片大片在线免费观看| 国产精品亚洲一级av第二区| 桃红色精品国产亚洲av| 国产午夜福利久久久久久| 美女cb高潮喷水在线观看 | 国内精品久久久久久久电影| 国产野战对白在线观看| 少妇的丰满在线观看| 亚洲国产精品sss在线观看| 女人被狂操c到高潮| 亚洲成人精品中文字幕电影| 91麻豆av在线| 草草在线视频免费看| 一卡2卡三卡四卡精品乱码亚洲| 一级a爱片免费观看的视频| 亚洲精品456在线播放app | 欧美色视频一区免费| 在线观看免费视频日本深夜| 成人无遮挡网站| 婷婷亚洲欧美| 日韩av在线大香蕉| 国产精品一区二区三区四区免费观看 | 两性午夜刺激爽爽歪歪视频在线观看| 欧美一区二区国产精品久久精品| 精品国内亚洲2022精品成人| 亚洲18禁久久av| 精品久久久久久久久久免费视频| 深夜精品福利| 人妻丰满熟妇av一区二区三区| 欧美午夜高清在线| 日韩欧美国产在线观看| 国产欧美日韩一区二区三| 国产精品久久电影中文字幕| 黄色女人牲交| 最新美女视频免费是黄的| 草草在线视频免费看| 亚洲av电影不卡..在线观看| 色噜噜av男人的天堂激情| 狂野欧美激情性xxxx| 男女午夜视频在线观看| 色视频www国产| www.自偷自拍.com| 午夜激情福利司机影院| 99国产极品粉嫩在线观看| 狂野欧美白嫩少妇大欣赏| 每晚都被弄得嗷嗷叫到高潮| 狂野欧美白嫩少妇大欣赏| 国产三级中文精品| 女警被强在线播放| 女人高潮潮喷娇喘18禁视频| 国产亚洲欧美98| 最好的美女福利视频网| 欧美3d第一页| 久久久国产欧美日韩av| 精品无人区乱码1区二区| 成人国产一区最新在线观看| 亚洲人成伊人成综合网2020| 日韩欧美精品v在线| 精品久久蜜臀av无| 少妇熟女aⅴ在线视频| 日本免费a在线| 亚洲国产欧美网| 成在线人永久免费视频| 亚洲一区二区三区不卡视频| 欧美日韩乱码在线| 国产野战对白在线观看| bbb黄色大片| 久久久久久九九精品二区国产| 亚洲欧美日韩高清专用| 午夜免费成人在线视频| 亚洲男人的天堂狠狠| 少妇丰满av| 亚洲精品456在线播放app | 九色成人免费人妻av| 亚洲av成人一区二区三| 啪啪无遮挡十八禁网站| 欧美日韩黄片免| 国产麻豆成人av免费视频| 亚洲国产精品999在线| 国产成人啪精品午夜网站| 五月玫瑰六月丁香| 黑人操中国人逼视频| 91久久精品国产一区二区成人 | 亚洲精品在线观看二区| 亚洲欧美精品综合久久99| 丰满的人妻完整版| 99国产精品99久久久久| 欧美zozozo另类| 亚洲 欧美 日韩 在线 免费| 亚洲人成伊人成综合网2020| 午夜a级毛片| 欧美一级a爱片免费观看看| 国产精品自产拍在线观看55亚洲| 曰老女人黄片| 国产欧美日韩一区二区精品| 亚洲欧美日韩无卡精品| 国产av一区在线观看免费| 亚洲精品粉嫩美女一区| 又黄又粗又硬又大视频| 男人的好看免费观看在线视频| 大型黄色视频在线免费观看| 校园春色视频在线观看| АⅤ资源中文在线天堂| 国产成+人综合+亚洲专区| 久久精品91无色码中文字幕| 大型黄色视频在线免费观看| 精品久久久久久成人av| 天堂√8在线中文| 特级一级黄色大片| 嫁个100分男人电影在线观看| 欧美+亚洲+日韩+国产| 女人被狂操c到高潮| 在线永久观看黄色视频| 国产精品野战在线观看| 色播亚洲综合网| 亚洲熟女毛片儿| 免费在线观看亚洲国产| 久久这里只有精品中国| 国产激情偷乱视频一区二区| 亚洲黑人精品在线| 我的老师免费观看完整版| 又爽又黄无遮挡网站| 国产精品,欧美在线| 99久久99久久久精品蜜桃| 母亲3免费完整高清在线观看| 亚洲一区二区三区色噜噜| 欧美黄色淫秽网站| 日本五十路高清| 婷婷丁香在线五月| 老汉色av国产亚洲站长工具| 99国产精品一区二区三区| 一边摸一边抽搐一进一小说| 人人妻,人人澡人人爽秒播| 色尼玛亚洲综合影院| 久久久久久久午夜电影| 婷婷精品国产亚洲av| 国产美女午夜福利| 久久这里只有精品中国| 少妇的逼水好多| 国产精品 国内视频| 悠悠久久av| 色综合欧美亚洲国产小说| 97超视频在线观看视频| 又黄又粗又硬又大视频| tocl精华| 搡老岳熟女国产| 久久久精品大字幕| 91在线精品国自产拍蜜月 | 国产一区二区在线av高清观看| 久久久久国产精品人妻aⅴ院| 国产欧美日韩一区二区精品| 亚洲国产看品久久| 精品国内亚洲2022精品成人| 日韩av在线大香蕉| 好男人电影高清在线观看| 国产精品久久电影中文字幕| 久久久国产精品麻豆| 变态另类成人亚洲欧美熟女| 欧美色欧美亚洲另类二区| 国产91精品成人一区二区三区| 搡老熟女国产l中国老女人| 桃红色精品国产亚洲av| 日韩欧美精品v在线| 欧美一级a爱片免费观看看| 91在线精品国自产拍蜜月 | 90打野战视频偷拍视频| 欧美日韩综合久久久久久 | 伊人久久大香线蕉亚洲五| 欧美国产日韩亚洲一区| 久久久久久大精品| 九九在线视频观看精品| 久久久国产成人精品二区| 精品乱码久久久久久99久播| 超碰成人久久| 在线观看日韩欧美| 国产精品av视频在线免费观看| 日韩欧美在线乱码| 嫁个100分男人电影在线观看| 日韩欧美精品v在线| 中文字幕久久专区| 国产精品久久久久久人妻精品电影| 日本免费一区二区三区高清不卡| 欧美中文综合在线视频| 90打野战视频偷拍视频| 夜夜看夜夜爽夜夜摸| 久久草成人影院| 亚洲熟妇熟女久久| 国产精品1区2区在线观看.| 日本撒尿小便嘘嘘汇集6| 亚洲av美国av| 国产免费男女视频| av女优亚洲男人天堂 | 窝窝影院91人妻| 亚洲五月天丁香| 18禁观看日本| 欧美大码av| 我要搜黄色片| 国产高清视频在线播放一区| 丰满人妻熟妇乱又伦精品不卡| av在线天堂中文字幕| 999久久久精品免费观看国产| 色综合欧美亚洲国产小说| 欧美一区二区国产精品久久精品| 99视频精品全部免费 在线 | 99热只有精品国产| 国内精品一区二区在线观看| 黄色片一级片一级黄色片| 1024香蕉在线观看| 亚洲欧美日韩东京热| 国产成人av教育| 亚洲,欧美精品.| 免费一级毛片在线播放高清视频| 丝袜人妻中文字幕| 搡老岳熟女国产| 一区二区三区国产精品乱码| 高清毛片免费观看视频网站| 巨乳人妻的诱惑在线观看| 中文字幕高清在线视频| 久久久久国内视频| 不卡一级毛片| 99久久精品国产亚洲精品| 亚洲国产看品久久| 国产aⅴ精品一区二区三区波| 久久久久久久午夜电影| 亚洲在线自拍视频| 亚洲av第一区精品v没综合| 嫩草影视91久久| 91老司机精品| 嫩草影院入口| 亚洲国产精品sss在线观看| 精品国产乱子伦一区二区三区| 九色成人免费人妻av|